Showing 461 - 480 results of 20,793 for search '"therapy"', query time: 0.10s Refine Results
  1. 461

    Value of the Ratio of Monocytes to Lymphocytes for Monitoring Tuberculosis Therapy by Wei Wang, Li-fei Wang, Yan-yan Liu, Fang Yang, Lei Zhu, Xian-hui Zhang

    Published 2019-01-01
    “…A total of 151 patients who had newly diagnosed active tuberculosis with tuberculosis therapy in hospital and 129 healthy controls were selected. …”
    Get full text
    Article
  2. 462

    Anti-VEGF-therapy for pseudoxanthoma elasticum (case reports) by A.D. Chuprov, S.M. Kim, E.A. Pidodniy, A.M. Iserkepova

    Published 2023-08-01
    “…</p> <p> For citation: Chuprov A.D., Kim S.M., Pidodniy E.A., Iserkepova A.M. Anti-VEGF-therapy for pseudoxanthoma elasticum (case reports). …”
    Get full text
    Article
  3. 463

    Intimate Partner Violence from Schema Therapy Perspective by Ayse Gokcen Gundogmus, Suheyla Dogan Bulut, Yasir Safak

    Published 2019-08-01
    “…Schema Therapy developed by Jeffrey Young is a psychotherapy method used in the treatment of many psychiatric disorders, particularly personality disorders. …”
    Get full text
    Article
  4. 464
  5. 465
  6. 466
  7. 467

    Challenges and Controversies in Human Mesenchymal Stem Cell Therapy by Barbara Lukomska, Luiza Stanaszek, Ewa Zuba-Surma, Pawel Legosz, Sylwia Sarzynska, Katarzyna Drela

    Published 2019-01-01
    “…Stem cell therapy is being intensely investigated within the last years. …”
    Get full text
    Article
  8. 468

    Elucidating Clinical Queries for Tailored Therapy in Patients with Prolactinoma by Min-Ho Lee, Jae Won Hong, Kyungwon Kim, Cheol Ryong Ku, Eun Jig Lee

    Published 2024-12-01
    “…This review aims to enhance clinical decision-making and patient care for endocrinologists by focusing on several key factors: predictive markers of DA sensitivity, clinical characteristics and suitability for transsphenoidal adenomectomy as a potential first-line treatment, factors determining the successful withdrawal of DAs after prolonged use, safety concerns during pre/post-pregnancy and breastfeeding, and determinants of tumor aggressiveness. Through tailored therapy—a patient-focused, multidisciplinary approach— we aim to improve the management of prolactinoma patients.…”
    Get full text
    Article
  9. 469

    An Overview of the Impact of Statin Therapy on Cardiac Incident Risk by Urszula Świrk, Aleksandra Paprocka, Karolina Kalinowska, Paulina Fijałek, Jan Karczmarz, Marika Gutowska, Agnieszka Kosińska, Wiktoria Belcarz, Joanna Orzechowska, Michał Orzechowski

    Published 2025-02-01
    “… Statin therapy is a cornerstone in preventing and managing cardiovascular diseases, particularly in reducing the risk of cardiac incidents. …”
    Get full text
    Article
  10. 470
  11. 471
  12. 472
  13. 473

    GH Therapy in Non–Growth Hormone-Deficient Children by Chiara Guzzetti, Anastasia Ibba, Valeria Incandela, Sandro Loche

    Published 2024-12-01
    “…In this paper, we review the rhGH therapy in children with conditions other than GHD.…”
    Get full text
    Article
  14. 474

    Endoscopic Ultrasound-Guided Intratumoural Therapy for Pancreatic Cancer by Brian M Yan, Jacques Van Dam

    Published 2008-01-01
    “…EUS FNI may be an exciting new technique for the delivery of desperately needed novel therapies for pancreatic cancer.…”
    Get full text
    Article
  15. 475

    Teamwork is Essential to Success: Sports Physical Therapy is No Exception by Kevin E Wilk, Christopher A Arrigo, James R Andrews

    Published 2021-02-01
    “…International Journal of Sports Physical Therapy…”
    Get full text
    Article
  16. 476
  17. 477
  18. 478

    Hepatorenal Syndrome: Outcome of Response to Therapy and Predictors of Survival by Jan Heidemann, Christoph Bartels, Christoph Berssenbrügge, Hartmut Schmidt, Tobias Meister

    Published 2015-01-01
    “…Univariate analysis of factors influencing the success of terlipressin therapy and Cox regression analysis of factors influencing survival was carried out. …”
    Get full text
    Article
  19. 479
  20. 480